Glucagon-like peptide-1 receptor and sarcoglycan delta genetic variants can affect cardiovascular risk in chronic kidney disease patients under hemodialysis.
Terranegra A, Arcidiacono T, Macrina L, Brasacchio C, Pivari F, Mingione A, Tomei S, Mezzavilla M, Silcock L, Cozzolino M, Palmieri N, Conte F, Sirtori M, Rubinacci A, Soldati L, Vezzoli G.
Terranegra A, et al. Among authors: sirtori m.
Clin Kidney J. 2020 Feb 5;13(4):666-673. doi: 10.1093/ckj/sfz182. eCollection 2020 Aug.
Clin Kidney J. 2020.
PMID: 32905248
Free PMC article.